No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.
about
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibilityRed-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]CYP17 genetic polymorphism, breast cancer, and breast cancer risk factorsEndogenous hormones and the aetiology of breast cancer.Future possibilities in the prevention of breast cancer: role of genetic variation in breast cancer prevention.CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control studyCYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.CYP17 and breast cancer: no overall effect, but what about interactions?CYP17 gene polymorphism in relation to breast cancer risk: a case-control studyA comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast.Cytochrome P450 polymorphisms as risk factors for steroid hormone-related cancers.Male breast cancer: a gender issue.CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 statusFactors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis.Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women.Genetic variation in the CYP17 gene and recurrent spontaneous abortions.CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer.BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms.Association between CYP17 T-34C rs743572 and breast cancer risk.A polymorphism in the CYP17 gene is associated with prostate cancer risk.Association between CYP17 gene polymorphism and risk of breast cancer in young women.Cytochrome P450c17alpha 5'-untranslated region *T/C polymorphism in endometriosis.No association of the 5' promoter region polymorphism of CYP17 with breast cancer risk in Japan.
P2860
Q24679438-3D2109B4-86C0-4ED1-897C-68E1645E0AF6Q24794752-55F74FA4-6826-4467-8B53-5F50405F4332Q24795469-10280259-1D25-4EEC-B478-A1D699F9EB49Q24800587-79FAF521-B5B4-43A5-B916-792613D3FB40Q24803327-679A9DA6-FCD9-4E61-B5C9-7513E83AB4E1Q24810611-D13BEFAB-8CD0-4C35-B3E9-B8E37F6BBB2EQ24810733-EBDEC231-C566-4ED6-A8E0-15106FEA9068Q25257341-3972920E-CD81-4EE5-AE8B-7C01E736038AQ25257428-ACD74C1D-932C-43C0-8000-B2E72946B12BQ34115258-5E216BF8-673B-4784-BEAB-4347A86FC22EQ34291721-FE9499C7-9D72-4B79-B00B-B444ED77F9CFQ34783067-6FCC8281-828C-4519-879A-A5E66024D2FCQ36559277-C783444E-ED0E-447D-A0D7-DE1CFF74EB3DQ36648775-7ADE1CD3-F2E0-4E57-A941-4EF85A213086Q37665345-990D45CC-47F4-425A-8F49-D950D6A898BBQ39213223-6B2082E1-3C53-4E79-A637-B5D9D3E68837Q44183331-2E37AA91-5838-4E08-8126-FADC0E38750BQ45135781-92D0CFF5-D3C3-4CD2-A19B-48EE4751066BQ45190967-31C2C36E-EF21-4EA6-9303-3529FE347B1BQ46054315-50326713-9588-4AF3-AA91-37908258F8C3Q49163775-85A18E14-90E4-47C8-8EF1-C4C0608474E8Q53407864-FDD98F04-D6E7-4FDD-B9F5-158FEBFEA042Q53421511-D9B8C7E1-788F-44FD-812C-EB75944840C8Q54693813-036FA8E7-C05F-4A3E-8FF8-E9E5216D42F6Q55517845-4BFABB8D-C9B3-42C9-A179-3603B4EA580B
P2860
No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
No association between a polym ...... P17 and risk of breast cancer.
@ast
No association between a polym ...... P17 and risk of breast cancer.
@en
type
label
No association between a polym ...... P17 and risk of breast cancer.
@ast
No association between a polym ...... P17 and risk of breast cancer.
@en
prefLabel
No association between a polym ...... P17 and risk of breast cancer.
@ast
No association between a polym ...... P17 and risk of breast cancer.
@en
P2093
P2860
P50
P356
P1476
No association between a polym ...... P17 and risk of breast cancer.
@en
P2093
B A Ponder
C S Healey
J M Lipscombe
K L Redman
N A Foster
P2860
P2888
P304
P356
10.1038/BJC.1998.340
P407
P577
1998-06-01T00:00:00Z